This inventor holds 5 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1990-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Swindon, GB (1991 - 1993)
- Swindon Wilts, GB (1993)
- Wootton Bassett, GB (1990 - 1995)
Company Filing History:
Years Active: 1990-1995
Title: The Innovative Contributions of Charles J Hedgecock
Introduction
Charles J Hedgecock is a notable inventor based in Wootton Bassett, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds with pharmaceutical applications. With a total of 5 patents to his name, Hedgecock's work has garnered attention for its potential therapeutic benefits.
Latest Patents
Hedgecock's latest patents include innovative compounds such as 3-cycloalkyl-propanamides. This compound is characterized by its diverse structural possibilities, including various tautomeric forms and functional groups that contribute to its anti-inflammatory activity. Another notable patent is for 7-cyclopropyl-imidazodiazepines, which are designed to possess tranquillizing properties. These compounds are formulated to be non-toxic and pharmaceutically acceptable, showcasing Hedgecock's commitment to safety and efficacy in his inventions.
Career Highlights
Throughout his career, Hedgecock has been associated with Roussel Uclaf, a company known for its focus on pharmaceutical innovations. His work has not only advanced the field of medicinal chemistry but has also contributed to the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Hedgecock has collaborated with esteemed colleagues such as Elizabeth A Kuo and David P Kay. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Charles J Hedgecock's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents reflect a dedication to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile